Zenitar Biomedical

Chengdu, China · Founded 2019 · In IPO Registration

Developer of innovative biopharmaceutical technologies designed to accelerate the discovery and commercialization of new drugs. Zenitar Biomedical is based in Chengdu, China and was founded in 2019. Its last reported valuation was $479 million in Nov 2025. It has raised $165 million.

Last reported valuation

$479.0M

Oct 2026

Priced at

—

Total raised

$165.1M

Last round

—

How much has Zenitar Biomedical raised?

$165.1Macross 0 recorded rounds

Free account

More of Zenitar Biomedical with a free account

·The complete investor list: 27 names
·Watch Zenitar Biomedical: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Zenitar Biomedical investors

27 investors are on record for Zenitar Biomedical, including Qiming Venture Partners, 5Y Capital, Lanchi Ventures and Tencent Investment.

For fundraisers

Raising for a company like Zenitar Biomedical?

27 investors have backed Zenitar Biomedical.

See all 27 investors →

Frequently asked about Zenitar Biomedical

How much has Zenitar Biomedical raised?: Zenitar Biomedical has raised $165.1M in total across 0 recorded funding rounds.